Inventor · disambiguated record
Ankita Srivastava
Also filed as: SRIVASTAVA ANKITA
10 granted patents·15 pending applications·21 citations·filing 2014–2024
86Inventor score
Top patents by PatentIndex Score
25 records- 0196US11912778B2Methods of engineering transferrin receptor binding polypeptidesDENALI THERAPEUTICS INC·Filed 2022·Granted Feb 27, 2024·2 cites·17 claims
- 0293US12162948B2Methods of engineering transferrin receptor binding polypeptidesDENALI THERAPEUTICS INC·Filed 2024·Granted Dec 10, 2024·1 cites·16 claims
- 0393US10870837B2Fusion proteins comprising enzyme replacement therapy enzymesDENALI THERAPEUTICS INC·Filed 2019·Granted Dec 22, 2020·9 cites·47 claims
- 0489US11866742B2Fusion proteins comprising enzyme replacement therapy enzymesDENALI THERAPEUTICS INC·Filed 2020·Granted Jan 9, 2024·2 cites·35 claims
- 0589US11643446B2Progranulin variantsDENALI THERAPEUTICS INC·Filed 2022·Granted May 9, 2023·4 cites·50 claims
- 0688US11795232B2Engineered transferrin receptor binding polypeptidesDENALI THERAPEUTICS INC·Filed 2019·Granted Oct 24, 2023·2 cites·38 claims
- 0788US2024141058A1Methods of engineering transferrin receptor binding polypeptidesDENALI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0887US2024018253A1Engineered transferrin receptor binding polypeptidesDENALI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0985US2025297023A1Methods of engineering transferrin receptor binding polypeptidesDENALI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1084US12383530B2Pharmaceutical combination for the treatment of melanomaPIRAMAL ENTPR LTD·Filed 2023·Granted Aug 12, 2025·0 cites·19 claims
- 1182US2024024432A1Engineered transferrin receptor binding polypeptidesDENALI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1282US2024271326A1Methods of engineering transferrin receptor binding polypeptidesDENALI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1379US12240902B2Anti-TREM2 antibodies and methods of use thereofDENALI THERAPEUTICS INC·Filed 2021·Granted Mar 4, 2025·1 cites·20 claims
- 1474US2023265137A1Progranulin variantsDENALI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1572US11839591B2Pharmaceutical combination for the treatment of melanomaPIRAMAL ENTPR LTD·Filed 2021·Granted Dec 12, 2023·0 cites·15 claims
- 1669US2022220172A1Progranulin variantsDENALI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1768US2023406898A1Fusion proteins comprising progranulinDENALI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1867US2020369746A1Engineered transferrin receptor binding polypeptidesDENALI THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1964US2021188925A1Progranulin variantsDENALI THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2062US11007174B2Pharmaceutical combination for the treatment of melanomaPIRAMAL ENTPR LTD·Filed 2014·Granted May 18, 2021·0 cites·19 claims
- 2160US2021284702A1Fusion proteins comprising progranulinDENALI THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2259US2019282544A1Pharmaceutical combination for the treatment of melanomaPIRAMAL ENTPR LTD·Filed 2018·Application pending·0 cites
- 2359US2020277584A1Fusion proteins comprising enzyme replacement therapy enzymesDENALI THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2457US2024228650A9CD3/BCMA/CD38 Trispecific AntibodiesIchnos Sciences SA·Filed 2023·Application pending·0 cites
- 2538US2020277373A1Anti-trem2 antibodies and methods of use thereofDENALI THERAPEUTICS INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ankita Srivastava files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →